The role of third-generation cephalosporins in pediatric gramnegative CNS infections remains undefined. Therefore, we reviewed our experience with these drugs in 42 patients (ages 19 days to 11 years) with ventriculitis complicating hydrocephalus (14), or meningitis (28), 30 treated with moxalactam and 12 with ceftriaxone. Moxalactam dosages were 50-100 mg/kg q 8 hrs for 10-29 days, and ceftriaxone 50 mg/kg q 12 hrs for 10-31 days. Etiologic agents included H. influenzae type b (25), E. coli (8), klebsiella (6), 5. cloacae (2), and salmonella (1). Median minimal inhibitory concentrations of moxalactam and ceftriaxone respectively for hemophilus were 0.055 and 0.003 pg/ml, and for enteric bacilli were 0.45 and 0.12 pg/ml. Levels in CSF or ventricular fluid ranged from 18-60 ug/ml for moxalactam and from 8.9-13.7 pg/ml for ceftriaxone. The bacteriologic cure rate was 100%. Clinical cures were demonstrated in 41/42 patients, with one patient unevaluable. No significant clinical side effects were noted; one patient had transient eosinophilia. The only complications were 2 patients with oral candidiasis and one with enterococcal ventricular superinfection. No bleeding problems or significant diarrhea were encountered. Because of the safety and efficacy of moxalactam and ceftriaxone in the treatment of both gram-negative enteric and hemophilus CNS infections in children, these agents may now represent the drugs of choice for such infections.
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IMPAIRED PYROGEN PRODUCTION BY FETAL AND NEWBORN RABBIT LEUKOCYTES. Kathleen H. Chance, Michael E. lo51 M i l l e r , Boyd W. Goetzman, Anthony T. C h r Department o m a t r i c s , U n i v e r s i t y o f C a l i f o r n i a , Davis, CA ' S i n c e newborns o f t e n do not respond t o i n f e c t i o n w i t h fever, t h e i r w h i t e c e l l s may not be capable o f producing pyrogens. We i n v e s t i g a t e d t h i s p o s s i b i l i t y i n leukocytes obtained from 23 and 26 day g e s t a t i o n f e t a l r a b b i t s and term (31-33 days g e s t a t i o n ) , 2 day o l d , 4 day o l d , and a d u l t r a b b i t s . T h e i r leukocytes were incubated w i t h E. c o l i endotoxin and t h e r e s u l t a n t %,pernatants, p o s s i b l y c o n t a i n i n g pyrogen, were i n j e c t e d i t . t o a d u l t r a b b i t s ( r e c i p i e n t s ) whose r e c t a l temperatures were being monitored. Blood samples were drawn from t h e r e c i p i e n t s b e f o r e and 2 112 hours a f t e r t h e i n j e c t i o n f o r t h e determination o f t o t a l n e u t r o p h i l counts. The r e c i p i e n t s developed f e v e r f o l l o w i n g supernatant i n j e c t i o n s o f leukocyte preparations from some f e t a l , term, and 2 day o l d r a b b i t s , and a l l 4 day o l d and a d u l t r a b b i t s . When t h e r e was no f e b r i l e response, t h e r e was nevertheless a 2 t o 4 f o l d increase i n t h e t o t a l n e u t r o p h i l count. Both t h e PMN and f e b r i l e responses were suppressed by administering pregnant a d u l t plasma t o t h e r e c i p i e n t .
The apparent impaired pyrogen production by leukocytes from younger animals may e x p l a i n t h e i r f a i l u r e t o develop f e v e r w i t h i n f e c t i o n . While generation o f i n s u f f i c i e n t o r incomplete pyrogens a r e p o s s i b l e mechanisms, t h e t r a n s p l acental t r a n s f e r o f a m a t e r n a l l y produced i n h i b i t o r appears more l i k e l y .
INCREASED LEUKOCYTE ALKALINE PHOSPHATASE I N SICK NEONATES. Kathleen H. Chance, E l l i o t Goldstein, Boyd W. Goetzman, W i l l i a m L i p p e r t , and Richard M. Donovan, School o f Medicine, Dept. o f P e d i a t r i c s and I n t e r n a l Medicine, U n i v e r s i t y o f C a l i f o r n i a , Davis.
A1 k a l i ne phosphatase (LAP) and myeloperoxidase (MPO) were evaluated i n polymorphonuclear leukocytes (PMNs) from neonates u s i n g a computer-assisted cytospectrophotometer. T h i s method allowed q u a n t i t a t i v e enzyme determinations w i t h i n each PMN. P o p u l a t i o n d i s t r i b u t i o n s were determined f o r 100 i n d i v i d u a l c e l l s . Of t h e 10 i n f a n t s studied, 8 were ill, 3 w i t h congenital pneumonia and 5 w i t h o u t proven i n f e c t i o n , and 2 were w e l l pre-term i n f a n t s . PMNs were obtained from a l l d u r i n g t h e f i r s t week o f l i f e and from 5 d u r i n g t h e t h i r d week, as w e l l . The 8 ill i n f a n t s showed a broad d i s t r i b u t i o n o f LAP a c t i v i t y i n t h e i r PMNs i n t h e f i r s t week o f l i f e , w i t h 75.4t25.2% (73S.D.) o f PMNs having LAP a c t i v i t y g r e a t e r than t h e 95th p e r c e n t i l e o f our a d u l t c o n t r o l s . By t h e t h i r d week o f l i f e , t h e percent o f PMNs had s i g n i f i c a n t l y diminished t o 35.6+33.9% (m5.D.) ( p < .05). The 2 w e l l preterm i n f a n t s i n t h e f i r s t week o f l i f e had o n l y 7 9 % (x?S.D.) o f PMNs w i t h a c t i v i t y g r e a t e r than t h e 95th p e r c e n t i l e f o r a d u l t c o n t r o l s . The d i s t r i b u t i o n o f MPO a c t i v i t y d i d not d i f f e r from a d u l t c o n t r o l s i n any i n f a n t .
I n summary, we found increased PMN LAP a c t i v i t y i n t h e f i r s t week o f l i f e i n s i c k neonates w i t h and w i t h o u t i n f e c t i o n as compared w i t h a d u l t s and w e l l neonates. Decreasing LAP a c t i v i t y i n t h e t h i r d week o f l i f e corresponded w i t h c l i n i c a l improvement. Thus, d i f f e r e n c e s i n i n t r a c e l l u l a r LAP a c t i v i t y appear t o be due t o p a t h o l o g i c r a t h e r than maturational processes. The risk of bilirubin-related brain injury may be increased by perinatal or neonatal infection. To determine whether Gram-negative bacteremia acutely increases transfer of bilirubin ant albumin from blood to brain, 6 adult rats were injected with 10 E. coli to produce positive bloof 2~ultures, and then infused while awake with bilirubin (BR) and I albumin (ALB) via indwelling catheters for 180 minutes. 3 of 6 rats with positive blood cultures had lethargy or temperature instability during the experiment. At 180 mins, the animals were sacrificed for brain BR and ALB concentrations. Compared to 5 controls, there were no differences in serum or brain BR and ALB in the bacteremic rats, as shown in the In the adult rat, bacteremia does not cause acute changes in permeability of the blood-brain barrier to bilirubin or albumin. If sepsis does increase the risk of bilirubin injury to the central nervous system, systemic metabolic or circulatory changes due to sepsis or acute effects of endotoxin, rather than acute bacterial effects on the blood brain barrier, may be more likely reasons for this association.
GRAM-NEGATIVE BACTEREMIA DOES NOT INCREASE ALBUMIN

OR BILIRUBIN CONTENT IN BRAINS OF ADULT RATS. ~h u
L a r r y K. Pickering, Phi 1 J o h Z College students spending t h e summer i n Mexico were s t u d i e d f o r t h e development o f diarrhea. Stool specimens were c o l l e c t e d from s i c k and asymptomatic students. 188 episodes o f g a s t r o e n t e r i t i s were evaluated f o r salmonella, s h i g e l l a , campylobacter, enteropathogenic E. a, e n t e r o t o x i g e n i c E. This i s t h e f i r s t evidence t h a t Shiga t o x i n production by E.
c o l i may commonly cause e n t e r i t i s . S u p p o r t e d by NIH g r a n t HD-13201-05 It is generally accepted that the ideal culture plate medium for Group A beta-hemolytic streptococci (GABHS) is 5% sheep's blood agar (SEA), with human, rabbit or horse blood being acceptable substitutes. During a recent study of acute pharyngitis conducted in Costa Rica, because of a relative unavailability of sheep's blood, human blood agar plates were utilized. After 29 of 30 throat cultures were negative for GABHS in spite of excellent growth of other organisms, sheep's blood agar was obtained, and a standard GABHS strain (J174A4) from the American Type Culture Collection was reconstituted. Sheep and human blood agar plates were inoculated, then incubated both aerobically and anerobically. After 24 hours of incubation, poor colony growth with minimal hemolysis was noted on both the aerobic and anerobic human blood plates, with excellent growth and beta hemolysis on SEA. Frozen samples from the 30 original throat cultures were subsequently grown on SBA and typed by means of latex agglutination. Four specimens in addition to the original positive culture were confirmed as positive for GABHS. One was suspicious but could not be isolated for confirmation. Preliminary data suggest that human blood agar is not an acceptable substitute for SBA as some lots may contain factors which may inhibit growth of GABHS.
